MedTrace Logo

Blood Serum Concentrations of Routine Drugs in Patients Treated in the Intensive Care Unit.

NCT02305004 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 359

Last updated 2018-04-17

No results posted yet for this study

Summary

To follow up the result of a quality measurement based on the results of a new routine for drug analysis introduced during a period of time in the intensive care unit. To ensure the quality of the dose regimen of routine drugs for sedation and analgesics. The aim is also to find out if the routine analysis can give information about if the self- intoxicated patients have taken drugs that were primarily not suspected.To know the serum concentrations of routine drugs in patients who died and will undergo autopsy.

Conditions

  • Serum Concentrations
  • Intoxication
  • Post Mortem Concentrations

Sponsors & Collaborators

  • Forensic Toxicology Laboratory, Sweden

    collaborator OTHER

  • Uppsala University

    lead OTHER

Principal Investigators

  • Sten Rubertsson, MdPhd · Uppsala University Hospital

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02305004 on ClinicalTrials.gov